KOLD News 13 Staff
A Tucson research facility, Visions Clinical Research, is testing the gel treatment thats less invasive than some current treatments being used to treat symptoms of the human papillomavirus.
The facility says the gel is for high-risk HPV, which puts women at high risk for cervical cancer.
According to the National Cancer Institute says there is no cure for HPV.
The study medication already is being used in Europe. The Tucson facility hopes to recruit women for the study to see if the gel is safe and effective.
It says it's looking for women, aged 18 to 40, who have had an abnormal pap smear result or who have been diagnosed with cervical high-risk HPV.
If you'd like more information, you may call the study coordinator, Felice Anderson, at Visions Clinical Research at 546-4700.
The company that makes the gel, 3M Pharmaceuticals, is paying for the study.
7831 N. Business Park Drive
Tucson, AZ 85743